| Ajanta Pharma has reported a sales turnover of Rs 120.51 crore and a net profit of Rs 11.95 crore for the quarter ended Dec '10. | | For the quarter ended Dec 2009 the sales turnover was Rs 94.66 crore and net profit was Rs 7.69 crore. |
|
| | Quarterly Results of Ajanta Pharma | -------- in Rs. Cr. -------- |
|
| Dec '09 | | | Sep '10 | Dec '10 | | Sales Turnover | 94.66 | | | 112.51 | 120.51 | | Other Income | 0.29 | | | 0.36 | 0.68 | | Total Income | 94.95 | | | 112.87 | 121.19 | | Total Expenses | 77.26 | | | 91.59 | 97.71 | | Operating Profit | 17.40 | | | 20.92 | 22.80 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 17.69 | | | 21.28 | 23.48 | | Interest | 4.29 | | | 4.35 | 3.46 | | PBDT | 13.40 | | | 16.92 | 20.02 | | Depreciation | 4.78 | | | 5.90 | 6.22 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 8.62 | | | 11.02 | 13.80 | | Tax | 0.93 | | | 0.97 | 1.85 | | Net Profit | 7.69 | | | 10.05 | 11.95 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 6.52 | | | 8.52 | 10.13 | | Book Value | -- | | | -- | -- | | Equity | 11.80 | | | 11.80 | 11.80 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
